ARRDC3 and breast carcinoma: Inhibition of ITG β4 recycling by ARRDC3 also has implications in regulating tumorigenic and invasive potential of breast cancer cell-derived EVs by reducing the levels of ITG β4+ EVs that confer invasive potentials to non-invasive recipient cells.